Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Leg Med (Tokyo) ; 71: 102496, 2024 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-39154432

RESUMEN

It is reported that immunostaining of Myoglobin (Mb) is useful for forensic diagnosis. In this study, we investigated the condition of fixation of striated muscle in 10 % neutral-buffered formalin to obtain appropriate stationarity of Mb in immunostaining. Firstly, criteria for staining intensity and definition of the stainability of examined were determined for sheep muscle tissue. Sheep myocardial tissue was fixed using 10 % neutral-buffered formalin under the 21 different conditions based on combinations of the following: three ratios of volume of formalin (mL) to weight of myocardium (g) (RFM) of 1, 4 or 9, 7 durations of fixation (DF) of 0.5, 3 or 6 h, and 1, 2, 5 or 7 days. Secondly, detection of Mb diffused form skeletal muscle from autopsy cases into formalin during fixation were confirmed by ELISA. Finally, the evaluation of stainability of Mb of striated muscle in routine autopsy examinations was confirmed using sheep staining intensity standards. From this experimental investigation, it has been demonstrated that the most suitable formalin fixation condition for using Mb staining in forensic diagnosis is RFM4 with a fixation time of at least DF 3 h up to 1 day. It was evident that staining intensity decreases with fixation durations exceeding 2 days, irrespective of the RFM. Thus, the fixation time was deemed the most influential factor affecting the staining properties of Mb staining in skeletal muscle tissue. When conducting Mb staining using striated muscle as an evaluation sample, particular attention should be paid to the fixation time.

2.
Intern Med ; 2024 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-39048363

RESUMEN

Malignant cardiac lymphoma is rare and commonly involves nodules on the right side of the heart. We herein report a case of malignant cardiac lymphoma with diffuse extension into the left ventricle. The patient was a woman in her 60s who complained of dyspnea and malaise. Echocardiography revealed left ventricular hypertrophy (LVH), and magnetic resonance imaging revealed diffuse contrast enhancement on delayed contrast. Cardiac catheterization and a myocardial biopsy suggested heart failure due to cardiac malignant lymphoma, and diastolic dysfunction was mild despite LVH. The patient underwent chemotherapy, and her cardiac function improved and was maintained.

3.
Intern Med ; 63(6): 821-827, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38494729

RESUMEN

Myocardial calcification in myocarditis is rare and may be linked to poor outcomes. We herein report a case of fulminant myocarditis with massive myocardial calcification and its pathological outcomes at autopsy. A 49-year-old man experienced chest pain and was diagnosed with acute myocarditis. His cardiac function did not recover despite mechanical circulatory support in combination with V-A extracorporeal membrane oxygenation and IMPELLA CP®. He eventually developed sepsis and gastrointestinal bleeding and died on day 27. Diffuse myocardial calcification was observed on computed tomography at autopsy. The pathological autopsy depicted that calcification filled every myocardial cell in the left ventricle.


Asunto(s)
Cardiomiopatías , Miocarditis , Masculino , Humanos , Persona de Mediana Edad , Miocarditis/patología , Ventrículos Cardíacos , Miocardio/patología , Autopsia
4.
Anal Chem ; 2024 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-38343188

RESUMEN

As more families are acquiring pets and the opportunities for wild animals to appear in human neighborhoods are increasing, the number of cases and accidents involving animals is increasing. Hence, the need to identify animal species from blood left over at accident sites is increasing. Human hemoglobin is used as a marker for human blood. Although tandem mass spectrometry is the dominant methodology used in proteomics research, peptide mass fingerprinting, given its instant applicability, may be useful for screening animal species, as the amino acid sequences of hemoglobin from various animals differ. In this study, solutions that were easily purified─using hemoglobin reagents from humans, Japanese macaques, bears, cattle, goats, sheep, sika deer, pigs, wild boars, dogs, cats, and nutrias─were digested by trypsin, and subjected to database searched using Mascot. No candidate proteins were found in the blood of goats, sheep, sika deer, wild boars, pigs, or nutrias. However, bloodstains from all animal species except nutria (which is not registered in the database) yielded candidates, which were identified as the hemoglobin of origin or its relatives. This difference may be attributed to more contaminants being included in blood. Further narrowing was possible using the average mass obtained via infusion electrospray ionization mass spectrometry measurement of the undigested solution in Mascot results. Saliva, urine, semen, and sweat collected from humans were also examined and searched for mascots, but no hits were obtained. In conclusion, this method may be useful for estimating animal species and identifying blood in forensic science.

5.
JMA J ; 7(1): 133-135, 2024 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-38314411

RESUMEN

Massive methanol exposure can lead to severe and detrimental effects that can result in death or brain death. As organs from patients with brain death after methanol ingestion are less likely to be recovered, these patients have been considered marginal donors. We present a case of successful multiple organ transplantation (heart, lungs, and kidneys) from a methanol-poisoned patient. Our experience illustrates that donor death from methanol intoxication does not preclude organ transplantation.

6.
Heart Vessels ; 39(6): 486-495, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38393377

RESUMEN

This study examined the effects of pemafibrate, a selective peroxisome proliferator-activated receptor α agonist, on the serum biochemical parameters of male patients with coronary artery disease and metabolic syndrome (MetS). This was a post hoc analysis of a randomized, crossover study that treated hypertriglyceridemia with pemafibrate or bezafibrate for 24 weeks, followed by a crossover of another 24 weeks. Of the 60 patients enrolled in the study, 55 were male. Forty-one of 55 male patients were found to have MetS. In this sub-analysis, male patients with MetS (MetS group, n = 41) and those without MetS (non-MetS group, n = 14) were compared. The primary endpoint was a change in fasting serum triglyceride (TG) levels during pemafibrate therapy, and the secondary endpoints were changes in insulin resistance-related markers and liver function parameters. Serum TG levels significantly decreased (MetS group, from 266.6 to 148.0 mg/dL, p < 0.001; non-MetS group, from 203.9 to 97.6 mg/dL, p < 0.001); however, a percent change (%Change) was not significantly different between the groups (- 44.1% vs. - 51.6%, p = 0.084). Serum insulin levels and homeostasis model assessment of insulin resistance significantly decreased in the MetS group but not in the non-MetS group. %Change in liver enzyme levels was markedly decreased in the MetS group compared with that in the non-MetS group (alanine aminotransferase, - 25.1% vs. - 11.3%, p = 0.027; gamma-glutamyl transferase, - 45.8% vs. - 36.2%, p = 0.020). In conclusion, pemafibrate can effectively decrease TG levels in patients with MetS, and it may be a more efficient drug for improving insulin resistance and liver function in such patients.


Asunto(s)
Benzoxazoles , Butiratos , Enfermedad de la Arteria Coronaria , Estudios Cruzados , Hipertrigliceridemia , Resistencia a la Insulina , Síndrome Metabólico , Humanos , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/tratamiento farmacológico , Síndrome Metabólico/complicaciones , Síndrome Metabólico/diagnóstico , Hipertrigliceridemia/sangre , Hipertrigliceridemia/tratamiento farmacológico , Hipertrigliceridemia/complicaciones , Hipertrigliceridemia/diagnóstico , Persona de Mediana Edad , Enfermedad de la Arteria Coronaria/sangre , Enfermedad de la Arteria Coronaria/tratamiento farmacológico , Benzoxazoles/uso terapéutico , Benzoxazoles/farmacología , Butiratos/uso terapéutico , Butiratos/farmacología , Resultado del Tratamiento , Anciano , Triglicéridos/sangre , Hipolipemiantes/uso terapéutico , Hipolipemiantes/farmacología , Biomarcadores/sangre , PPAR alfa/agonistas , Bezafibrato/uso terapéutico , Bezafibrato/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA